治疗生殖道感染推荐用药的研究——79家五倍可利胶囊用户的调查报告

Research on Recommended Medicine Used for Treatment in National RTI Intervention Project-- The Investigating Reports on 79 Family Planning Clinics using "WuBeiKeLi" Capsule.

目的:评估五倍可利胶囊对常见女性生殖道感染(包括念珠菌性、滴虫性、细菌性阴道病以及复合感染)的治疗效果,以及相关的综合性能,为生殖道感染干预工程筛选推荐用药。方法:按照安全性、疗效广谱、药价相对低廉、难以替代4项标准,采用函调方式,在全国24个省份所涉79个县级计划生育服务站中进行。结果:认为五倍可利临床使用安全或比较安全的合计为100％;认为临床很有效及有明显疗效的合计83.5％,无效的为0;平均使用五倍可利治疗过3种以上阴道炎(病)的占100％;认为不可替代的为63.3％。结论:五倍可利胶囊具有较高的安全性、较高的疗效和相对广谱的特点,特别在实施生殖道感染干预工程的农村地区具有肯定的推广价值,可鼓励推广应用。

Objective : Evaluating the remedial effects and relevant general function of ' Wu Bei Ke Li' on RTI including candidal vaginitis, trichomonas vaginitis, bacterial vaginosis and complex infection, selecting and recommending medicine for treating RTI. Methods : According to the four standards of the safety , broad -spectrum, relatively unexpensive and unsubstituted, letter - investigations were carried out among 79 county family planning clinics in 24 provinces of the country . Results: 100% clinics considered that ' Wu Bei Ke Li' was safe or comparatively safe in clinical treatment. 83.5% clinics considered that 'Wu Bei Ke Li' was very effective or obviously effective in clinical treatment, no clinic considered it was invalid. 100% clinics used ' Wu Bei Ke Li' to treat more than three vaginitis. 63. 3% clinics considered it was unsubstituted. Conclusion: 'Wu Bei Ke Li' has great safety, superior effects and relative broad -spectrum, thus it is valuable in applying and extending in RTI intervention project in the rural areas.